Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope

Md Yuzaiful Md Yusof; Eve M D Smith; Sammy Ainsworth; Kate Armon; Michael W Beresford; Morgan Brown; Lindsey Cherry; Christopher J Edwards; Kalveer Flora; Rebecca Gilman; Bridget Griffiths; Caroline Gordon; Paul Howard; David Isenberg; Natasha Jordan; Arvind Kaul; Peter Lanyon; Philip M Laws; Liz Lightsone; Hanna Lythgoe; Christian D Mallen; Stephen D Marks; Naomi Maxwell; Elena Moraitis; Clare Nash; Ruth J Pepper; Clarissa Pilkington; Antonios Psarras; Heather Rostron; Jade Skeates; Sarah Skeoch; Dalila Tremarias; Chris Wincup; Asad Zoma; Edward M Vital

doi:10.1093/rap/rkad093

Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope

Md Yuzaiful Md Yusof, Eve M D Smith, Sammy Ainsworth, Kate Armon, Michael W Beresford, Morgan Brown, Lindsey Cherry, Christopher J Edwards, Kalveer Flora, Rebecca Gilman, Bridget Griffiths, Caroline Gordon, Paul Howard, David Isenberg, Natasha Jordan, Arvind Kaul, Peter Lanyon, Philip M Laws, Liz Lightsone, Hanna LythgoeChristian D Mallen, Stephen D Marks, Naomi Maxwell, Elena Moraitis, Clare Nash, Ruth J Pepper, Clarissa Pilkington, Antonios Psarras, Heather Rostron, Jade Skeates, Sarah Skeoch, Dalila Tremarias, Chris Wincup, Asad Zoma, Edward M Vital

Inflammation and Ageing

Research output: Contribution to journal › Review article › peer-review

48 Downloads (Pure)

Abstract

The objective of this guideline is to provide up-to-date, evidence-based recommendations for the management of SLE that builds upon the existing treatment guideline for adults living with SLE published in 2017. This will incorporate advances in the assessment, diagnosis, monitoring, non-pharmacological and pharmacological management of SLE. General approaches to management as well as organ-specific treatment, including lupus nephritis and cutaneous lupus, will be covered. This will be the first guideline in SLE using a whole life course approach from childhood through adolescence and adulthood. The guideline will be developed with people with SLE as an important target audience in addition to healthcare professionals. It will include guidance related to emerging approved therapies and account for National Institute for Health and Care Excellence Technology Appraisals, National Health Service England clinical commissioning policies and national guidance relevant to SLE. The guideline will be developed using the methods and rigorous processes outlined in 'Creating Clinical Guidelines: Our Protocol' by the British Society for Rheumatology.

Original language	English
Article number	rkad093
Number of pages	9
Journal	Rheumatology Advances in Practice
Volume	7
Issue number	3
DOIs	https://doi.org/10.1093/rap/rkad093
Publication status	Published - 5 Dec 2023

Bibliographical note

Access to Document

10.1093/rap/rkad093Licence: Creative Commons: Attribution (CC BY)

YusofM2024ManagementFinal published version, 1.04 MBLicence: Creative Commons: Attribution (CC BY)

Cite this

Md Yusof, M. Y., Smith, E. M. D., Ainsworth, S., Armon, K., Beresford, M. W., Brown, M., Cherry, L., Edwards, C. J., Flora, K., Gilman, R., Griffiths, B., Gordon, C., Howard, P., Isenberg, D., Jordan, N., Kaul, A., Lanyon, P., Laws, P. M., Lightsone, L., ... Vital, E. M. (2023). Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope. Rheumatology Advances in Practice, 7(3), Article rkad093. https://doi.org/10.1093/rap/rkad093

@article{11f7c3d1a6974ccbac7b2b1f0c179276,

title = "Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope",

abstract = "The objective of this guideline is to provide up-to-date, evidence-based recommendations for the management of SLE that builds upon the existing treatment guideline for adults living with SLE published in 2017. This will incorporate advances in the assessment, diagnosis, monitoring, non-pharmacological and pharmacological management of SLE. General approaches to management as well as organ-specific treatment, including lupus nephritis and cutaneous lupus, will be covered. This will be the first guideline in SLE using a whole life course approach from childhood through adolescence and adulthood. The guideline will be developed with people with SLE as an important target audience in addition to healthcare professionals. It will include guidance related to emerging approved therapies and account for National Institute for Health and Care Excellence Technology Appraisals, National Health Service England clinical commissioning policies and national guidance relevant to SLE. The guideline will be developed using the methods and rigorous processes outlined in 'Creating Clinical Guidelines: Our Protocol' by the British Society for Rheumatology.",

author = "{Md Yusof}, {Md Yuzaiful} and Smith, {Eve M D} and Sammy Ainsworth and Kate Armon and Beresford, {Michael W} and Morgan Brown and Lindsey Cherry and Edwards, {Christopher J} and Kalveer Flora and Rebecca Gilman and Bridget Griffiths and Caroline Gordon and Paul Howard and David Isenberg and Natasha Jordan and Arvind Kaul and Peter Lanyon and Laws, {Philip M} and Liz Lightsone and Hanna Lythgoe and Mallen, {Christian D} and Marks, {Stephen D} and Naomi Maxwell and Elena Moraitis and Clare Nash and Pepper, {Ruth J} and Clarissa Pilkington and Antonios Psarras and Heather Rostron and Jade Skeates and Sarah Skeoch and Dalila Tremarias and Chris Wincup and Asad Zoma and Vital, {Edward M}",

note = "{\textcopyright} The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology.",

year = "2023",

month = dec,

day = "5",

doi = "10.1093/rap/rkad093",

language = "English",

volume = "7",

journal = "Rheumatology Advances in Practice",

issn = "2514-1775",

publisher = "Oxford University Press",

number = "3",

}

Md Yusof, MY, Smith, EMD, Ainsworth, S, Armon, K, Beresford, MW, Brown, M, Cherry, L, Edwards, CJ, Flora, K, Gilman, R, Griffiths, B, Gordon, C, Howard, P, Isenberg, D, Jordan, N, Kaul, A, Lanyon, P, Laws, PM, Lightsone, L, Lythgoe, H, Mallen, CD, Marks, SD, Maxwell, N, Moraitis, E, Nash, C, Pepper, RJ, Pilkington, C, Psarras, A, Rostron, H, Skeates, J, Skeoch, S, Tremarias, D, Wincup, C, Zoma, A & Vital, EM 2023, 'Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope', Rheumatology Advances in Practice, vol. 7, no. 3, rkad093. https://doi.org/10.1093/rap/rkad093

TY - JOUR

T1 - Management and treatment of children, young people and adults with systemic lupus erythematosus

T2 - British Society for Rheumatology guideline scope

AU - Md Yusof, Md Yuzaiful

AU - Smith, Eve M D

AU - Ainsworth, Sammy

AU - Armon, Kate

AU - Beresford, Michael W

AU - Brown, Morgan

AU - Cherry, Lindsey

AU - Edwards, Christopher J

AU - Flora, Kalveer

AU - Gilman, Rebecca

AU - Griffiths, Bridget

AU - Gordon, Caroline

AU - Howard, Paul

AU - Isenberg, David

AU - Jordan, Natasha

AU - Kaul, Arvind

AU - Lanyon, Peter

AU - Laws, Philip M

AU - Lightsone, Liz

AU - Lythgoe, Hanna

AU - Mallen, Christian D

AU - Marks, Stephen D

AU - Maxwell, Naomi

AU - Moraitis, Elena

AU - Nash, Clare

AU - Pepper, Ruth J

AU - Pilkington, Clarissa

AU - Psarras, Antonios

AU - Rostron, Heather

AU - Skeates, Jade

AU - Skeoch, Sarah

AU - Tremarias, Dalila

AU - Wincup, Chris

AU - Zoma, Asad

AU - Vital, Edward M

PY - 2023/12/5

Y1 - 2023/12/5

N2 - The objective of this guideline is to provide up-to-date, evidence-based recommendations for the management of SLE that builds upon the existing treatment guideline for adults living with SLE published in 2017. This will incorporate advances in the assessment, diagnosis, monitoring, non-pharmacological and pharmacological management of SLE. General approaches to management as well as organ-specific treatment, including lupus nephritis and cutaneous lupus, will be covered. This will be the first guideline in SLE using a whole life course approach from childhood through adolescence and adulthood. The guideline will be developed with people with SLE as an important target audience in addition to healthcare professionals. It will include guidance related to emerging approved therapies and account for National Institute for Health and Care Excellence Technology Appraisals, National Health Service England clinical commissioning policies and national guidance relevant to SLE. The guideline will be developed using the methods and rigorous processes outlined in 'Creating Clinical Guidelines: Our Protocol' by the British Society for Rheumatology.

AB - The objective of this guideline is to provide up-to-date, evidence-based recommendations for the management of SLE that builds upon the existing treatment guideline for adults living with SLE published in 2017. This will incorporate advances in the assessment, diagnosis, monitoring, non-pharmacological and pharmacological management of SLE. General approaches to management as well as organ-specific treatment, including lupus nephritis and cutaneous lupus, will be covered. This will be the first guideline in SLE using a whole life course approach from childhood through adolescence and adulthood. The guideline will be developed with people with SLE as an important target audience in addition to healthcare professionals. It will include guidance related to emerging approved therapies and account for National Institute for Health and Care Excellence Technology Appraisals, National Health Service England clinical commissioning policies and national guidance relevant to SLE. The guideline will be developed using the methods and rigorous processes outlined in 'Creating Clinical Guidelines: Our Protocol' by the British Society for Rheumatology.

U2 - 10.1093/rap/rkad093

DO - 10.1093/rap/rkad093

M3 - Review article

C2 - 38058676

SN - 2514-1775

VL - 7

JO - Rheumatology Advances in Practice

JF - Rheumatology Advances in Practice

IS - 3

M1 - rkad093

ER -

Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope

Abstract

Bibliographical note

Access to Document

Fingerprint

Cite this